These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1933581)

  • 21. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S; Schlosberg M; Fallon M; Thomas S; Movsowitz C; Ismail F
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor-I and beta 2 microglobulin in patients with osteoporosis.
    Zofková I; Kancheva RL; Bendlová B
    Calcif Tissue Int; 1997 Mar; 60(3):236-9. PubMed ID: 9069158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
    Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
    Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of osteoclastic development and function.
    Chambers TJ
    Ciba Found Symp; 1988; 136():92-107. PubMed ID: 3068019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.
    Zerwekh JE; Sakhaee K; Pak CY
    J Clin Endocrinol Metab; 1985 Mar; 60(3):615-7. PubMed ID: 3871787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development.
    Silve C; Grosse B; Tau C; Garabedian M; Fritsch J; Delmas PD; Cournot-Witmer G; Balsan S
    J Clin Endocrinol Metab; 1986 Mar; 62(3):583-90. PubMed ID: 3003145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF; Hermey DC; Popoff SN; Seifert MF
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet.
    Goulding A; Gold E; Fisher L
    Bone Miner; 1990 Mar; 8(3):185-93. PubMed ID: 2322693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption.
    Boonen S; Broos P; Verbeke G; Aerssens J; Van Herck E; Jans I; Dequeker J; Bouillon R
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M286-93. PubMed ID: 9310082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
    J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls.
    Wong MM; Rao LG; Ly H; Hamilton L; Ish-Shalom S; Sturtridge W; Tong J; McBroom R; Josse RG; Murray TM
    Osteoporos Int; 1994 Jan; 4(1):21-31. PubMed ID: 8148568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats.
    Chang KL; Hu YC; Hsieh BS; Cheng HL; Hsu HW; Huang LW; Su SJ
    Nutrition; 2013 Jan; 29(1):250-7. PubMed ID: 22858193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the hydroxylation of vitamin D in man.
    Loré F; Di Cairano G
    Ann Med Interne (Paris); 1986; 137(3):206-8. PubMed ID: 3767185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro.
    Skjødt H; Gallagher JA; Beresford JN; Couch M; Poser JW; Russell RG
    J Endocrinol; 1985 Jun; 105(3):391-6. PubMed ID: 3873510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.